SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-087270
Filing Date
2023-11-15
Accepted
2023-11-15 08:00:45
Documents
84
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_abvcbio.htm   iXBRL 10-Q 1504775
2 LICENSE AGREEMENT BETWEEN THE COMPANY AND AIBTL BIOPHARMA, INC f10q0923ex10-40_abvcbio.htm EX-10.40 34063
3 LICENSE AGREEMENT BETWEEN THE BIOLITE AND AIBTL BIOPHARMA, INC f10q0923ex10-41_abvcbio.htm EX-10.41 33861
4 CERTIFICATION f10q0923ex31-1_abvcbio.htm EX-31.1 8146
5 CERTIFICATION f10q0923ex31-2_abvcbio.htm EX-31.2 8138
6 CERTIFICATION f10q0923ex32-1_abvcbio.htm EX-32.1 5955
7 CERTIFICATION f10q0923ex32-2_abvcbio.htm EX-32.2 4021
  Complete submission text file 0001213900-23-087270.txt   8044718

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE abvc-20230930.xsd EX-101.SCH 83616
9 XBRL CALCULATION FILE abvc-20230930_cal.xml EX-101.CAL 41581
10 XBRL DEFINITION FILE abvc-20230930_def.xml EX-101.DEF 363574
11 XBRL LABEL FILE abvc-20230930_lab.xml EX-101.LAB 685749
12 XBRL PRESENTATION FILE abvc-20230930_pre.xml EX-101.PRE 376922
78 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_abvcbio_htm.xml XML 1064839
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 231409083
SIC: 2834 Pharmaceutical Preparations